East West Eye Institute
Welcome,         Profile    Billing    Logout  
 3 Trials 
12 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Salehi-had, Hani
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD

Active, not recruiting
3
388
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
03/25
Protocol AF, NCT04661358: Fenofibrate for Prevention of DR Worsening

Recruiting
3
560
US
Fenofibrate, Placebo
Jaeb Center for Health Research, National Institutes of Health (NIH), National Eye Institute (NEI), Juvenile Diabetes Research Foundation, Roche Pharma AG, The Leona M. and Harry B. Helmsley Charitable Trust
Diabetic Retinopathy
04/29
04/29
LEOPARD, NCT05608837: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema

Recruiting
2
24
US
OCS-01, dexamethasone ophthalmic suspension eye drops
Quan Dong Nguyen, Global Ophthalmic Research Center (GORC), Oculis
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative
01/25
04/25
GION, NCT06178055: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)

Recruiting
2
75
US
KUS121 high dose, KUS121 low dose, Sham procedure
Kyoto Drug Discovery and Development Co., Ltd.
Central Retinal Artery Occlusion
12/24
09/25
AN, NCT05727891: Evaluation of Tonabersat for DME

Recruiting
2
128
US
Tonabersat, Placebo
Jaeb Center for Health Research, National Institutes of Health (NIH), National Eye Institute (NEI), Juvenile Diabetes Research Foundation
Diabetic Macular Edema
11/24
05/25
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Recruiting
2
150
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin, Inc.
Diabetic Macular Edema (DME)
11/25
12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Recruiting
2
180
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin, Inc.
Neovascular Age-Related Macular Degeneration (nAMD)
11/25
12/25
NCT05230537: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Recruiting
2
146
Europe, US, RoW
Iptacopan (LNP023), Placebo
Novartis Pharmaceuticals
Age-Related Macular Degeneration
10/26
10/26
Protocol AM, NCT05145491: Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Recruiting
N/A
400
US
Immediate Vitrectomy, Deferred Vitrectomy
Jaeb Center for Health Research, National Institutes of Health (NIH), National Eye Institute (NEI), Juvenile Diabetes Research Foundation
Epiretinal Membrane
12/26
12/26
Liu, Alex
NCT06329791: A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)

Active, not recruiting
3
500
US
AZR-MD-001, AZR-MD-001 ophthalmic ointment 0.5%, Vehicle, AZR-MD-001 Vehicle
Azura Ophthalmics, ORA, Inc.
Dry Eye Disease
12/24
11/25
NCT05895500: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia

Completed
2a
103
US
Injection for SC administration (120mg/syringe), Tablet (50mg/tablet), oral
Nvision Laser Eye Centers
Dry Eye, Asthenopia
11/23
11/23
Ahn, Eric
NCT05895500: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia

Completed
2a
103
US
Injection for SC administration (120mg/syringe), Tablet (50mg/tablet), oral
Nvision Laser Eye Centers
Dry Eye, Asthenopia
11/23
11/23

Download Options